BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
45,69 € ↓ -1,20 (-2,56%)
2026-06-03
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership20,547 shares
Latest Disclosed Value $ 1,160,700
Strs Ohio reports 0.03% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 20,547 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $985,845 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 20,554 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -0.03% during the quarter. The current value of the position is $938,792 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 20,547 -7 -0.03 1,161 -5.00 0.0046
2026-02-02 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 20,554 8 0.04 1,222 9.80 0.0046
2025-10-30 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 20,546 2 0.01 1,113 -1.51 0.0041
2025-08-04 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 20,544 4,544 28.40 1,129 -0.18 0.0042
2025-05-28 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 16,000 0 0.00 1,131 7.61 0.0047
2025-05-28 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 16,000 0 0.00 1,052 -6.49 0.0042
2024-11-01 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 16,000 0 0.00 1,125 -14.65 0.0043
2024-08-05 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 16,000 0 0.00 1,317 131,600.00 0.0052
2024-05-13 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM_STK 09061G101 16,000 0 0.00 1 0.00 0.0056
2024-01-30 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 0 0.00 2 0.00 0.0064
2023-10-26 2023-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 0 0.00 1 0.00 0.0063
2023-10-26 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 0 1 0.0063
2023-07-31 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 -14,346 -47.27 1 -50.00 0.0059
2023-08-02 2023-03-31 13F/A-2 BIOMARIN PHARMACEUTICAL COM 09061G101 30,346 14,346 89.66 3 100.00 0.0128
2023-08-02 2023-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 30,346 3
2023-04-27 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 30,346 14,346 3 0.0152
2023-01-26 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 -12,959 -44.75 2 -99.96 0.0075
2022-10-27 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,959 12,959 80.99 2,454 85.21 0.0117
2022-07-25 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,000 -18,493 -53.61 1,325 -50.17 0.0060
2022-04-21 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,493 13,909 67.57 2,659 46.26 0.0097
2022-01-24 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,584 132 0.65 1,818 15.06 0.0063
2021-10-22 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,452 -719 -3.40 1,580 -10.53 0.0059
2021-07-26 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 21,171 -3,741 -15.02 1,766 -6.11 0.0064
2021-04-23 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,912 -432 -1.70 1,881 -15.35 0.0071
2021-01-25 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,344 -42,357 -62.56 2,222 -56.85 0.0086
2020-12-14 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67,701 -352,811 -83.90 5,150 -90.07 0.0216
2020-07-23 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 420,512 379,327 921.03 51,865 1,390.37 0.2267
2020-04-23 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,185 0 0.00 3,480 -0.06 0.0183
2020-01-24 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,185 0 0.00 3,482 25.48 0.0146
2019-10-21 2019-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 41,185 0 0.00 2,775 -21.32 0.0122
2019-10-21 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,185 0 2,775 12,282.3039
2019-07-25 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,185 -145,600 -77.95 3,527 -78.74 0.0157
2019-04-19 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 186,785 0 0.00 16,592 4.33 0.0752
2019-01-23 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 186,785 0 0.00 15,904 -12.19 0.0807
2018-10-19 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 186,785 49,200 35.76 18,112 39.75 0.0794
2018-08-06 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 137,585 -52,228 -27.52 12,960 -15.78 0.0558
2018-04-20 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 189,813 -210,483 -52.58 15,388 -56.89 0.0680
2018-01-23 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 400,296 -203,224 -33.67 35,694 -36.45 0.1525
2017-10-23 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 603,520 422 0.07 56,169 2.55 0.2412
2017-07-26 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 603,098 -13,101 -2.13 54,773 1.26 0.2440
2017-04-26 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 616,199 1,452 0.24 54,089 6.21 0.2343
2017-01-24 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 614,747 -4,398 -0.71 50,925 -11.10 0.2244
2016-10-27 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 619,145 127,589 25.96 57,283 49.79 0.2559
2016-07-26 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 491,556 165,472 50.75 38,243 42.19 0.1700
2016-04-25 2016-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 326,084 24,027 7.95 26,895 -15.00 0.1208
2016-01-28 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 302,057 11,923 4.11 31,643 3.56 0.1415
2015-10-21 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 290,134 -32,554 -10.09 30,556 -30.77 0.1454
2015-08-04 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 322,688 12,476 4.02 44,137 14.17 0.1938
2015-04-27 2015-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 310,212 8,398 2.78 38,658 41.69 0.1705
2015-04-21 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,658,619 38,407
2015-01-23 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 301,814 -42,500 -12.34 27,284 9.81 0.1183
2014-10-29 2014-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 344,314 0 0.00 24,846 15.99 0.1097
2014-10-20 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 344,314 24,846
2014-07-24 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 344,314 -2,600 -0.75 21,420 -9.48 0.0955
2014-04-28 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 346,914 -1,000 -0.29 23,663 -3.21 0.1064
2014-01-30 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 347,914 124,300 55.59 24,448 51.39 0.1099
2013-10-24 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 223,614 223,614 16,149 0.0712
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.